X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7362) 7362
Newspaper Article (174) 174
Newsletter (133) 133
Magazine Article (50) 50
Book Chapter (41) 41
Dissertation (4) 4
Conference Proceeding (3) 3
Publication (2) 2
Trade Publication Article (2) 2
Transcript (2) 2
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5295) 5295
bcg vaccine - administration & dosage (3861) 3861
science & technology (3747) 3747
life sciences & biomedicine (3485) 3485
male (2868) 2868
female (2854) 2854
bcg (2041) 2041
animals (2040) 2040
bcg vaccine - therapeutic use (1699) 1699
administration, intravesical (1434) 1434
tuberculosis (1412) 1412
middle aged (1330) 1330
immunology (1328) 1328
vaccination (1320) 1320
bcg vaccine - adverse effects (1230) 1230
aged (1228) 1228
adult (1217) 1217
bcg vaccine - immunology (1128) 1128
tuberculosis - prevention & control (1108) 1108
mice (1101) 1101
urinary bladder neoplasms - therapy (1004) 1004
vaccines (983) 983
abridged index medicus (910) 910
bcg vaccine (899) 899
infant (881) 881
child (863) 863
urinary bladder neoplasms - drug therapy (809) 809
bcg vaccines (807) 807
immunotherapy (787) 787
urology & nephrology (777) 777
infectious diseases (736) 736
bladder cancer (723) 723
adolescent (721) 721
urinary bladder neoplasms - pathology (669) 669
child, preschool (648) 648
immunization (609) 609
time factors (594) 594
infant, newborn (550) 550
mycobacterium bovis - immunology (540) 540
tuberculin test (528) 528
adjuvants, immunologic - administration & dosage (525) 525
treatment outcome (524) 524
health aspects (496) 496
cancer (486) 486
mycobacterium tuberculosis - immunology (486) 486
infections (484) 484
tuberculosis - immunology (483) 483
tuberculosis, pulmonary - prevention & control (483) 483
care and treatment (477) 477
research (468) 468
aged, 80 and over (463) 463
follow-up studies (458) 458
carcinoma, transitional cell - therapy (443) 443
research article (437) 437
mycobacterium bovis (436) 436
medicine, research & experimental (432) 432
research & experimental medicine (431) 431
microbiology (427) 427
risk factors (418) 418
antigens (409) 409
analysis (363) 363
medicine (341) 341
mice, inbred c57bl (340) 340
adjuvants, immunologic - therapeutic use (339) 339
combined modality therapy (339) 339
immune response (326) 326
oncology (323) 323
prognosis (323) 323
medical research (311) 311
mycobacterium tuberculosis (308) 308
mice, inbred balb c (306) 306
tuberculosis vaccines (306) 306
tuberculosis - epidemiology (301) 301
cytokines (297) 297
neoplasm staging (297) 297
antineoplastic agents - administration & dosage (294) 294
carcinoma, transitional cell - drug therapy (285) 285
urology (279) 279
retrospective studies (277) 277
urinary bladder neoplasms - surgery (277) 277
antigens, bacterial - immunology (276) 276
prospective studies (274) 274
clinical trials as topic (272) 272
general & internal medicine (270) 270
guinea pigs (268) 268
carcinoma, transitional cell - pathology (262) 262
disease models, animal (259) 259
science & technology - other topics (259) 259
children (258) 258
multidisciplinary sciences (256) 256
clinical trials (254) 254
bcg vaccine - pharmacology (249) 249
respiratory system (249) 249
drug therapy, combination (245) 245
carcinoma in situ - therapy (244) 244
medicine, general & internal (241) 241
immunity (240) 240
studies (234) 234
age factors (233) 233
prevention (233) 233
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6756) 6756
French (272) 272
Russian (258) 258
Japanese (191) 191
German (149) 149
Spanish (148) 148
Portuguese (66) 66
Italian (48) 48
Chinese (41) 41
Polish (40) 40
Hungarian (17) 17
Romanian (17) 17
Swedish (12) 12
Czech (10) 10
Norwegian (7) 7
Croatian (6) 6
Danish (6) 6
Dutch (6) 6
Finnish (6) 6
Serbian (4) 4
Turkish (4) 4
Bulgarian (3) 3
Arabic (2) 2
Hebrew (2) 2
Ukrainian (2) 2
Afrikaans (1) 1
Icelandic (1) 1
Korean (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Vaccine, ISSN 0264-410X, 2017, Volume 35, Issue 16, pp. 2084 - 2091
Highlights • BCG has no overall effect on the antibody response to pentavalent vaccine... 
Allergy and Immunology | Non-specific effects | Clinical trial | Children | Vaccine antibodies | BCG | Heterologous immunity | Immunology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Heptavalent Pneumococcal Conjugate Vaccine - administration & dosage | Heptavalent Pneumococcal Conjugate Vaccine - immunology | Adjuvants, Immunologic - administration & dosage | Poliovirus Vaccine, Inactivated - administration & dosage | Humans | Infant | Male | Haemophilus Vaccines - administration & dosage | Vaccines, Combined - administration & dosage | Vaccines, Combined - immunology | Poliovirus Vaccine, Inactivated - immunology | Haemophilus Vaccines - immunology | Pregnancy | Diphtheria-Tetanus-Pertussis Vaccine - administration & dosage | Diphtheria-Tetanus-Pertussis Vaccine - immunology | BCG Vaccine - immunology | Antibody Formation | Denmark | Female | Antibodies, Bacterial - blood | BCG Vaccine - administration & dosage | Infant, Newborn | Influenza vaccines | Clinical trials | Vaccination | Biopharmaceutics | Medical research | Influenza | Medicine, Experimental | Intervention | Neonates | Antibodies | Vaccines | Birth | Antibody response | Streptococcus infections | Pertussis | Randomization | Measles | Age | Immunoglobulins | Statistical analysis | Cytokines | Diphtheria | Girls | Whooping cough | Childbirth & labor | Studies | Tuberculosis | Serotypes | Tetanus | Index Medicus
Journal Article
Journal Article
The Journal of immunology (1950), ISSN 1550-6606, 08/2003, Volume 171, Issue 3, pp. 1602 - 1609
Heterologous prime-boost immunization strategies can evoke powerful T cell immune responses and may be of value in developing an improved tuberculosis vaccine... 
Life Sciences & Biomedicine | Immunology | Science & Technology | Immunodominant Epitopes - immunology | T-Lymphocyte Subsets - immunology | Lung - microbiology | Adjuvants, Immunologic - administration & dosage | Dose-Response Relationship, Immunologic | Spleen - immunology | Viral Vaccines - therapeutic use | Antigens, Bacterial - immunology | Mycobacterium tuberculosis - immunology | Molecular Sequence Data | Vaccines, Synthetic - immunology | Spleen - microbiology | Vaccinia virus - immunology | CD4-Positive T-Lymphocytes - immunology | Acyltransferases - administration & dosage | Female | Immunization Schedule | Adjuvants, Immunologic - therapeutic use | Injections, Intradermal | Amino Acid Sequence | CD4-Positive T-Lymphocytes - microbiology | CD8-Positive T-Lymphocytes - microbiology | Cells, Cultured | Acyltransferases - immunology | Immunization, Secondary - methods | Vaccines, Synthetic - therapeutic use | Antigens, Bacterial - administration & dosage | Lymph Nodes - immunology | Administration, Intranasal | Viral Vaccines - administration & dosage | Immunodominant Epitopes - administration & dosage | Animals | Nasal Mucosa - immunology | BCG Vaccine - immunology | Mice | Mice, Inbred BALB C | T-Lymphocyte Subsets - microbiology | BCG Vaccine - therapeutic use | Vaccines, Synthetic - administration & dosage | CD8-Positive T-Lymphocytes - immunology | Viral Vaccines - immunology | BCG Vaccine - administration & dosage | Lung - immunology | Lymph Nodes - microbiology | Index Medicus | Abridged Index Medicus
Journal Article
Clinical cancer research, ISSN 1078-0432, 02/2017, Volume 23, Issue 3, pp. 717 - 725
Purpose: Treatments with cancer vaccines may be delivered as combination therapies for better efficacy... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Immunotherapy - methods | Oligodeoxyribonucleotides - administration & dosage | Adjuvants, Immunologic - administration & dosage | Dose-Response Relationship, Immunologic | Humans | Lipid A - analogs & derivatives | Neoplasm Proteins - immunology | Carcinoma, Transitional Cell - therapy | Plant Extracts - administration & dosage | Cancer Vaccines - therapeutic use | Urinary Bladder Neoplasms - pathology | Immunization Schedule | Quillaja | Lipid A - administration & dosage | Cytokines - urine | Antigens, Neoplasm - immunology | Cancer Vaccines - administration & dosage | Cancer Vaccines - adverse effects | Combined Modality Therapy | Injections, Intramuscular | Lymphocytes, Tumor-Infiltrating - drug effects | Urinary Bladder Neoplasms - surgery | Carcinoma, Transitional Cell - pathology | Recombinant Proteins - immunology | Carcinoma, Transitional Cell - immunology | BCG Vaccine - adverse effects | Urinary Bladder Neoplasms - therapy | Urinary Bladder Neoplasms - immunology | Administration, Intravesical | BCG Vaccine - therapeutic use | Carcinoma, Transitional Cell - surgery | BCG Vaccine - administration & dosage | Cystectomy - methods | Therapy | Animal models | Drug delivery systems | Vaccination | Bladder | Lymphocytes T | Vaccines | Cancer therapies | Blood | Metastases | Cancer vaccines | Urinary bladder | Lymphocytes | Combined vaccines | Bacteria | Urine | Immune response | Immunostimulation | Invasiveness | BCG | Muscles | Adjuvants | Regression analysis | Patients | Bladder cancer | Experimental design | Infiltration | Cancer | Index Medicus
Journal Article
Vaccine, ISSN 0264-410X, 11/2015, Volume 33, Issue 48, pp. 6800 - 6808
Journal Article
Journal Article